BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Drug Development

  Merck & Co., Inc. Bone Drug Shows Benefits So Trial is Stopped

  July 12, 2012

   · 

  1 min read
• Job Trends

  Actelion Ltd. Plans to Cut 135 Jobs, Refocus Research Effort

  July 12, 2012

   · 

  4 min read
• Deals

  AstraZeneca PLC Buys Link Medicine Neuroscience Assets; Enters Alzheimer’s Pact

  July 12, 2012

   · 

  3 min read
• Drug Development

  Genentech, deCODE genetics, Inc. Identify Protective Gene Against Alzheimer’s, Cognitive Decline

  July 12, 2012

   · 

  4 min read
• Deals

  Hologic, Inc. to Pay Gen-Probe Incorporated CEO $6.9 Million to Stay on Board

  July 12, 2012

   · 

  13 min read
• Drug Development

  Gilead Sciences, Inc.'s Truvada Pill Urged for AIDS Prevention After Promising Studies

  July 12, 2012

   · 

  4 min read
• Drug Development

  Celgene Psoriatic Arthritis Drug Effective in Phase 3 Trial

  July 12, 2012

   · 

  6 min read
• Business

  NuVasive, Inc. Announces Conference Call and Webcast of Second Quarter 2012 Results

  July 12, 2012

   · 

  3 min read
• Drug Development

  Catalyst Pharmaceutical Partners, Inc. to Announce Top-Line Data From CPP-109 Phase II(b) Clinical Trial for the Treatment of Cocaine Addiction Earlier Than Expected

  July 12, 2012

   · 

  1 min read
• Business

  Trinity Biotech Announces Quarter 2 Financial Results EPS of 20 Cents Per ADR -- an Increase of 11%

  July 12, 2012

   · 

  1 min read